Jul 10, 2019

Universal flu vaccine means big bucks for biotech firms

Illustration: Rebecca Zisser/Axios

Osivax, a French developer of a universal flu vaccine, raised €8 million in Series A funding led by Noshaq.

Why it matters: Developing a universal flu vaccine is fast becoming biotech's holy grail.

  • Wednesday's deal comes just 1 day after a Cincinnati-based universal flu startup called Blue Water Vaccines raised $7 million, and a couple months after the U.S. National Institutes of Health launched clinical trials of its own. And then there were those nasal vaccine tests on llamas.

The bottom line: "It's an arms race of taxpayers versus private capital," says Axios' health care business reporter Bob Herman.

Go deeper

One year on — No end in sight for deadly Ebola outbreak

Health workers carry a coffin containing a victim of Ebola virus in Butembo in May. Photo: John Wessels/AFP/Getty Images

One year ago today, the Democratic Republic of the Congo declared an outbreak of Ebola. Since then, more than 1,800 people have died, the virus has been carried to the large city of Goma on the border of Rwanda and to nearby Uganda, and violence has killed health workers.

The big picture: Politics, violence and community suspicion are thwarting efforts to contain the virus, which shows no signs of abatement. Experts say this cycle could easily spiral out of control.

Go deeperArrowAug 1, 2019 - Health

Drugmakers stand to profit from vaccines thanks to climate change

A handful of drug companies with big vaccine portfolios are especially well-positioned to capitalize on the effects of climate change, according to a Morgan Stanley investors’ note.

The big picture: Climate change will be a business opportunity for some pharmaceutical companies. That’s nothing cynical — infectious diseases will spread faster and farther as the climate warms, and we treat infectious diseases with drugs.

Go deeperArrowJul 25, 2019

Measles in U.S. creeps back toward endemic status

Data: Centers for Disease Control and Prevention; Chart: Harry Stevens/Axios

The Centers for Disease Control and Prevention on Monday confirmed another 25 cases of measles last week, with Ohio and Alaska now reporting their first 2019 infections.

Why it matters: America is continuing its trek toward losing the "measles elimination status" it's had since 2000, with the greatest number of cases reported in the U.S. since 1992.

Go deeperArrowJul 23, 2019